Rubitecan

HCID 472335CAS 104195-61-1

기본 정보

표준 SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1
InChIKey
VHXNKPBCCMUMSW-FQEVSTJZSA-N
분자식
C20H15N3O6
평균 분자량
393.3 g/mol
단동위원소 질량
393.09608521

이름 및 식별자

우선 이름
Rubitecan
IUPAC
(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
영어명
Rubitecan
분자식
C20H15N3O6
분자량
393.35

이름 및 동의어

Rubitecan9-Nitrocamptothecin91421-42-09-nitro-20(S)-camptothecinOrathecinCamptogenRFS 2000RFS-2000NitrocamptothecinrubitecanumH19C446XXB9-nitro-20-(S)-camptothecin
이름 더 보기
9-Nitrocellulose camptothecine9-NCOratheciRUBETICANRubitecane9-NITRO-CPT
DTXSID7046752CHEBI:90225RFS20009-nitro-(20S)-camptothecinDTXCID50267521H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

데이터베이스 식별자

CAS
104195-61-1、91421-42-0
PubChem CID
472335
DTXSID
DTXSID7046752
ChEMBL
CHEMBL77305
ChEBI
CHEBI:90225
UNII
H19C446XXB
EC Number
995-853-7
Nikkaji
J448.357J

물성

구조 계산 물성

XLogP
0.8
극성 표면적
126 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
7
회전 가능 결합 수
1
무거운 원자 수
29

물리화학적 성질

녹는점
182 · 182-186°C
끓는 점
816.3 · 816.3±65.0 °C(Predicted)
밀도
1.63 · 1.63
인화점
106 ℃ · 106℃
저장 조건
Sealed in dry,Room Temperature
용해도
DMSO, 클로로포름, 메탄올에 용해됨

화학적 성질

Yellow Amorphous Powder

안전 및 규제

GHS 분류

GHS Classification · 5건

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H340 (100%): May cause genetic defects [Danger Germ cell mutagenicity];H350 (100%): May cause cancer [Danger Carcinogenicity];H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P203, P260, P264, P270, P280, P301+P317, P318, P319, P330, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%);Muta. 1B (100%);Carc. 1B (100%);STOT RE 2 (100%)

안전 데이터

wgk
3
rtecs
UQ0493300
HS 번호
29399990
safety_code
24/25
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

Mechanism of ActionRubitecan prevents DNA from unwinding during replication via DNA topoisomerase 1, therefore interfering with tumor growth.
MeSH Pharmacological Classification · 2건

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Compounds that inhibit the activity of DNA TOPOISOMERASE I.

응용 분야 · 1건

개요Rubitecan is a DNA topoisomerase I inhibitor. It inhibits DNA topoisomerase I and increases the fraction of supercoiled DNA in a cell-free assay in a concentration-dependent manner. Rubitecan inhibits the growth of A121 ovarian and H460 lung cancer cells (IC50s = 4 and 2 nM, respectively). It also inhibits the growth of doxorubicin-susceptible and -resistant MCF-7 breast cancer cells (IC50s = 2 and 3 nM, respectively). Rubitecan (4 mg/kg twice per week) reduces tumor growth in a U937 leukemia mouse xenograft model.

공급사50 곳

北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
成都普瑞法科技开发有限公司+86-028-82633397 18982077548 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]

추가 설명

정의ChEBI: A pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin.

관련 반응

7건

연결된 노트

불러오는 중…